Quotient Sciences

GHO Capital agrees sale of Quotient Sciences to Permira

London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, acknowledges the announcement from Quotient Sciences regarding its recapitalisation with global Private Equity Firm Permira: Quotient Sciences and global investment firm Permira today announced that a company backed by the Permira Funds has signed a definitive agreement to acquire… read more

Quotient Sciences acquires Pharmaterials

London, UK – GHO Capital, the European specialist investor in healthcare, acknowledges the announcement from its portfolio company Quotient Sciences regarding its acquisition of Pharmaterials, a UK-based Contract Development and Manufacturing Organisation. Quotient Sciences (“Quotient”), the early phase drug development services provider, announced that it has acquired Pharmaterials, a contract development and manufacturing organisation (CDMO)… read more

Quotient Clinical acquires QS Pharma from Charles River Laboratories International, Inc.

London, UK – GHO Capital, the European specialist investor in healthcare, is pleased to share today’s announcement from its portfolio company Quotient Clinical regarding its acquisition of QS Pharma, increasing its US presence and adding high potency molecule capabilities to its existing operations. Addition of contract development and manufacturing organisation increases scale of business and… read more

Subscribe to our email alerts

Email updates